Item 9.01 Financial Statements and Exhibits.

(a) Financial Statements of Businesses or Funds Acquired.

The audited financial statements of HistoTox Labs, Inc. as of and for the

fiscal year ended December 31, 2020, together with the notes thereto and the

1. report of the independent auditor thereon, were filed as Exhibit 99.3 to the


    Company's Current Report on Form 8-K filed April 20, 2021   and are
    incorporated herein by reference.


    The audited financial statements of Bolder BioPATH, Inc. as of and for the
    fiscal years ended December 31, 2019 and 2020, together with the notes thereto

2. and the report of the independent auditor thereon, were filed as

Exhibit 99.2 to the Company's Current Report on Form 8-K filed April 20,

2021 and are incorporated herein by reference.

(b) Pro Forma Financial Information.

1. The unaudited pro forma condensed combined financial information of the

Company, Bolder and Histotox is filed as Exhibit 99.1 to this Amendment No. 1.




(c) None.


(d) Exhibits

The following exhibits are being filed as part of this report:



Exhibit No.     Description
99.1              Unaudited pro forma condensed combined financial information of
                the Company, Bolder and Histotox.

© Edgar Online, source Glimpses